191 Publications (Page 4 of 8)
2015
Overall survival in newly diagnosed MM patients with del(17p): A report from the Connect MM Registry
Shah, Jatin JAbonour, RafatDurie, Brian GMehta, JayeshNarang, MohitTerebelo, Howard RGasparetto, CristinaToomey, KathleenHardin, James WSrinivasan, ShankarLarkins, GailRicafort, Rosanna JNagarwala, Yasir M and Rifkin, Robert M
Journal of Clinical Oncology, vol. 33, (no. 15_suppl), pp. 8582, 2015-05-20. | Journal Article
 
Phase 1 Study of a Hepcidin Antagonist, LY2787106, in Cancer-Associated Anemia
Vadhan-Raj, SarojAbonour, RafatGoldman, Jonathan WSmith, David ASlapak, Christopher ATiu, Ramon VWang, XuejingCallies, SophieCox, JoanneTuttle, Jay LLau, Yiu-Keung (James) and Roeland, Eric J
Blood, vol. 126, (no. 23), pp. 537, 2015-12-03. | Journal Article
 
Phase I/II Study of Lenalidomide and High Dose Melphalan As Preparative Regimen in Autologous Transplant in Myeloma: Report of Phase II Efficacy and Safety Data
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifFarag, SherifSilbermann, RebeccaSilbermann, RebeccaSilbermann, RebeccaCangany, MaryCangany, MaryCangany, MaryRush-Taylor, AnitaRush-Taylor, AnitaRush-Taylor, AnitaO'Bryant, RobinO'Bryant, RobinO'Bryant, RobinWood, LisaWood, LisaWood, LisaPearson, JeanPearson, JeanPearson, JeanSingleton, SarahSingleton, SarahSingleton, SarahBradley, AndreaBradley, AndreaBradley, AndreaAlthouse, SandraAlthouse, SandraAlthouse, SandraPerkins, SusanPerkins, SusanPerkins, SusanEstes, DebEstes, DebEstes, DebAbonour, RafatAbonour, Rafat and Abonour, Rafat
Blood, vol. 126, (no. 23), pp. 3193, 2015-12-03. | Journal Article
 
TG02, an Oral CDK9-Inhibitor, in Combination with Carfilzomib Demonstrated Objective Responses in Carfilzomib Refractory Multiple Myeloma Patients
Hofmeister, Craig CHofmeister, Craig CBerdeja, Jesus GBerdeja, Jesus GVesole, David HVesole, David HSuvannasankha, AttayaSuvannasankha, AttayaParrott, TracyParrott, TracyAbonour, Rafat and Abonour, Rafat
Blood, vol. 126, (no. 23), pp. 3052, 2015-12-03. | Journal Article
2014
Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)
Rifkin, Robert MAbonour, RafatShah, Jatin JMehta, JayeshNarang, MohitTerebelo, Howard RGasparetto, Cristina JThomas, Sachdev PToomey, KathleenHardin, James WLu, Jane JieKenvin, LaurieSrinivasan, ShankarRicafort, Rosanna JNagarwala, Yasir and Durie, Brian G. M
Blood, vol. 124, (no. 21), pp. 4749, 2014-12-06. | Journal Article
 
Connect MM®—the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease
Shah, Jatin JAbonour, RafatDurie, Brian G MMehta, JayeshNarang, MohitTerebelo, HowardGasparetto, Cristina JThomas, Sachdev PToomey, KathleenHardin, James WSrinivasan, ShankarRicafort, Rosanna JNagarwala, Yasir and Rifkin, Robert M
Blood, vol. 124, (no. 21), pp. 2106, 2014-12-06. | Journal Article
 
Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation
Ranganath, PraveenRanganath, PraveenRobertson, Michael JRobertson, Michael JAbonour, RafatAbonour, RafatSchwartz, Jennifer ESchwartz, Jennifer EFarag, SherifFarag, SherifWood, Lisa lWood, Lisa lKiel, PatrickKiel, PatrickNelson, Robert and Nelson, Robert
Blood, vol. 124, (no. 21), pp. 5874, 2014-12-06. | Journal Article
 
SP-029 WHAT ARE THE NEW AGENTS IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MYELOMA?
Abonour, Rafat
Leukemia Research, vol. 38, pp. S15, 2014. | Journal Article
2013
Changes in patient-reported outcomes in patients diagnosed with and treated for multiple myeloma in the Connect MM registry
Pashos, Chris LShah, Jatin JTerebelo, Howard RDurie, Brian GAbonour, RafatGasparetto, CristinaMehta, JayeshNarang, MohitThomas, SachdevToomey, KathleenSwern, Arlene SSullivan, Kristen AStreet, Thomas KKhan, Zeba MNourbakhsh, AliHardin, JamesWildes, Tanya Marya and Rifkin, Robert M
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 8586, 2013-05-20. | Journal Article
 
Children's emotional adaptation to parental BMT.
Spath, MaryFife, B LMonahan, P ODecker, C LAustin, J KAbonour, Rafat and Wood, L L
Bone marrow transplantation, vol. 48, (no. 1), pp. 135-40, 2013/Jan. | Journal Article
 
Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry
Terebelo, Howard RShah, Jatin JDurie, Brian GAbonour, RafatGasparetto, CristinaMehta, JayeshNarang, MohitThomas, Sachdev PToomey, KathleenPashos, Chris LSwern, Arlene SSullivan, Kristen AStreet, Thomas KSrinivasan, ShankarNourbakhsh, AliHardin, James W and Rifkin, Robert M
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 8596, 2013-05-20. | Journal Article
 
Evaluation of protocol mandated testing in E4A03, a randomized phase III study of CC-5013 plus dexamethasone versus CC-5013 plus low-dose dexamethasone in multiple myeloma (MM)
Callander, Natalie ScottJacobus, Susanna JWeiss, MatthiasKumar, ShajiFonseca, RafaelSiegel, David Samuel DiCapuaKatz, Michael SAbonour, RafatWilliams, Michael EGreipp, Philip R and Rajkumar, Vincent
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. e19517, 2013-05-20. | Journal Article
 
In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies.
Farag, Sherif SSrivastava, ShivaniMessina-Graham, StevenSchwartz, JenniferRobertson, Michael JAbonour, RafatCornetta, KennethWood, LisaSecrest, AngieStrother, R MJones, David R and Broxmeyer, Hal E
Stem cells and development, vol. 22, (no. 7), pp. 1007-15, 2013/Apr/1. | Journal Article
 
Phase I/II Dose Expansion Of a Multi-Center Trial Of Carfilzomib and Pomalidomide With Dexamethasone (Car-Pom-d) In Patients With Relapsed/Refractory Multiple Myeloma
Shah, Jatin JStadtmauer, Edward AAbonour, RafatCohen, Adam DBensinger, WilliamGasparetto, CristinaKaufman, Jonathan LLentzsch, SuzanneVogl, Dan TOrlowski, Robert ZKim, Erica LBialas, NataliaSmith, David D and Durie, Brian GM
Blood, vol. 122, (no. 21), pp. 690, 2013-11-15. | Journal Article
 
Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry
Abonour, RafatShah, Jatin JDurie, BrianTerebelo, HowardGasparetto, Cristina JMehta, JayeshNarang, MohitThomas, Sachdev PToomey, KathleenSullivan, Kristen ASrinivasan, ShankarNagarwala, Yasir and Rifkin, Robert M
Blood, vol. 122, (no. 21), pp. 3207, 2013-11-15. | Journal Article
 
Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
Suleiman, YamanSiddiqui, Bilal KBrames, Mary JAbonour, Rafat and Einhorn, Lawrence H
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 19, (no. 1), pp. 161-3, 2013/Jan. | Journal Article
 
Strategies to overcome barriers to accrual (BtA) to NCI-sponsored clinical trials: A project of the NCI-Myeloma Steering Committee Accrual Working Group (NCI-MYSC AWG)
Weiss, MatthiasGertz, Morie ALittle, Richard FRajkumar, VincentJacobus, Susanna JAbonour, RafatAnderson, Kenneth CarlBarlogie, BartCallander, Natalie ScottGorak, Edward JMatous, JeffreyMills, Glenn MorrisKane, Robert CKatz, Michael SJensen, LeeAnnOmel, JamesOrlowski, Robert ZRichardson, Paul Gerard Guy and Munshi, Nikhil C
Journal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 8592, 2013-05-20. | Journal Article
2012
A Multi-Center Phase I/II Trial of Carfilzomib and Pomalidomide with Dexamethasone (Car-Pom-d) in Patients with Relapsed/Refractory Multiple Myeloma
Shah, Jatin JStadtmauer, Edward AAbonour, RafatCohen, Adam DBensinger, William IGasparetto, CristinaKaufman, Jonathan LLentzsch, SuzanneVogl, Dan TOrlowski, Robert ZKim, Erica LMcKinley, Marti B and Durie, Brian G M
Blood, vol. 120, (no. 21), pp. 74, 2012-11-16. | Journal Article
 
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
Benson, Don MHofmeister, Craig CPadmanabhan, SwaminathanSuvannasankha, AttayaJagannath, SundarAbonour, RafatBakan, CourtneyAndre, PascaleEfebera, Yvonne ATiollier, JérômeCaligiuri, Michael A and Farag, Sherif S
Blood, vol. 120, (no. 22), pp. 4324-33, 2012/Nov/22. | Journal Article
 
A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifFarag, SherifSilbermann, RebeccaSilbermann, RebeccaSilbermann, RebeccaObryant, RobinObryant, RobinObryant, RobinWood, Lisa lWood, Lisa lWood, Lisa lHuljak, AbigailHuljak, AbigailHuljak, AbigailSecrest, AngieSecrest, AngieSecrest, AngieCrean, Colin DCrean, Colin DCrean, Colin DAbonour, RafatAbonour, Rafat and Abonour, Rafat
Blood, vol. 120, (no. 21), pp. 3146, 2012-11-16. | Journal Article
 
Connect MM: The multiple myeloma (MM) disease registry—Incidence of second primary malignancies (SPM)
Rifkin, Robert MAbonour, RafatFonseca, RafaelGasparetto, CristinaMehta, JayeshNarang, MohitPashos, Chris LThomas, Sachdev PShah, Jatin JTerebelo, Howard RToomey, KathleenMinton, NeilSrinivasan, ShankarStreet, ThomasSullivan, Kristen and Durie, Brian G
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 8037, 2012-05-20. | Journal Article
 
Early Evidence of Anabolic Bone Activity of BHQ880, a Fully Human Anti-DKK1 Neutralizing Antibody: Results of a Phase 2 Study in Previously Untreated Patients with Smoldering Multiple Myeloma At Risk for Progression
Munshi, Nikhil CMunshi, Nikhil CAbonour, RafatAbonour, RafatBeck, Joseph TBeck, Joseph TBensinger, WilliamBensinger, WilliamFacon, ThierryFacon, ThierryStockerl-Goldstein, KeithStockerl-Goldstein, KeithBaz, RachidBaz, RachidSiegel, David SSiegel, David SNeben, KaiNeben, KaiLonial, SagarLonial, SagarSuvannasankha, AttayaSuvannasankha, AttayaBilic, SanelaBilic, SanelaChica, SandraChica, SandraMukhopadhyay, SubhenduMukhopadhyay, SubhenduIsaacs, RandiIsaacs, RandiJagannath, Sundar and Jagannath, Sundar
Blood, vol. 120, (no. 21), pp. 331, 2012-11-16. | Journal Article
 
Identification of Significant Barriers to Accrual (BtA) to NCI Sponsored Multiple Myeloma – Clinical Trials (MM-CT): A Step towards Improving Accrual to Clinical Trials
Weiss, MatthiasJacobus, SusannaAbonour, RafatAnderson, Kenneth CBarlogie, BartCallander, NatalieGorak, Edward JHoering, AntjeKane, Robert CKatz, Michael SMatous, JeffreyMills, Glenn MOmel, JamesOrlowski, Robert ZRajkumar, S. VincentRichardson, Paul GJensen, LeeAnnLittle, Richard FGertz, Morie A and Munshi, Nikhil C
Blood, vol. 120, (no. 21), pp. 3165, 2012-11-16. | Journal Article
 
Novel combination treatments targeting chronic myeloid leukemia stem cells.
Al Baghdadi, TareqAbonour, Rafat and Boswell, H. S
Clinical lymphoma, myeloma & leukemia, vol. 12, (no. 2), pp. 94-105, 2012/Apr. | Journal Article
 
Observations of second primary malignancy in patients with multiple myeloma.
Ormerod, AnneFausel, Christopher AAbonour, Rafat and Kiel, Patrick J
Clinical lymphoma, myeloma & leukemia, vol. 12, (no. 2), pp. 113-7, 2012/Apr. | Journal Article